PACS · PACS Group, Inc. · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-09-16 | Jergensen Joshua |
President & COO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.57 to $43.565 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
36,502 |
| 2026-09-16 | Jergensen Joshua |
President & COO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.575 to $43.75 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
3,498 |
| 2026-09-15 | Hancock Mark |
Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.51 to $44.435 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
21,084 |
| 2026-09-15 | Hancock Mark |
Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $41.47 to $42.465 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
104,132 |
| 2026-09-15 | Hancock Mark |
Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.47 to $43.4628 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
30,466 |
| 2026-09-14 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.12 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
317 |
| 2026-09-14 | Hancock Mark |
Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.885 to $45.13 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
6,634 |
| 2026-09-14 | Hancock Mark |
Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.885 to $44.8845 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
137,684 |
| 2026-09-11 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.76 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
10,529 |
| 2026-09-10 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.4775 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
8,771 |
| 2026-09-09 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.89 to $43.66 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
4,758 |
| 2026-09-08 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.29 to $43.90 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
21,001 |
| 2026-09-08 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.25 to $43.22 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
3,056 |
| 2026-09-04 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.11 to $43.10 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
22,829 |
| 2026-09-04 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.14 to $43.16 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
243 |
| 2026-09-03 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.07 to $43.24 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
858 |
| 2026-09-03 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.065 to $43.06 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
19,315 |
| 2026-09-02 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.20 to $43.78 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
6,348 |
| 2026-09-02 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.20 to $43.19 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
17,435 |
| 2026-09-01 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.99 to $43.19 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
1,368 |
| 2026-09-01 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $41.92 to $42.90 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
22,789 |
| 2026-08-21 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.05 to $44.045 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
31,654 |
| 2026-08-21 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.05 to $44.52 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
27,590 |
| 2026-08-20 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.30 to $44.29 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
77,427 |
| 2026-08-20 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.31 to $45.165 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
13,879 |
| 2026-08-19 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.84 to $44.80 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
84,650 |
| 2026-08-19 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.845 to $44.86 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
67 |
| 2026-08-18 | Hancock Mark |
Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner |
Gift↓
Filing footnotes — Common Stock (Direct)
Represents a bona fide gift made by the Reporting Person to a charitable donor-advised fund. |
Common Stock
|
88,000 |
| 2026-08-18 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.81 to $44.67 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
66,797 |
| 2026-08-17 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.805 to $43.8025 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
9,758 |
| 2026-08-17 | Murray Jason Hulse |
Director, Co-Founder, CEO & Chairman, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.81 to $44.51 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
74,844 |
| 2026-08-14 | Conway Patrick Hugh |
Director |
Sell↓
|
Common Stock
|
3,497 |
| 2026-08-12 | Jergensen Joshua |
President & COO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.15 to $46.125 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
36,375 |
| 2026-08-12 | Jergensen Joshua |
President & COO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.13 to $45.12 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
3,625 |
| 2026-07-15 | Jergensen Joshua |
President & COO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.75 to $45.78 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
233 |
| 2026-07-15 | Jergensen Joshua |
President & COO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.74 to $44.735 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
7,440 |
| 2026-07-15 | Jergensen Joshua |
President & COO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.74 to $45.735 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
32,327 |
| 2026-07-15 | Hancock Mark |
Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.07 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
3,332 |
| 2026-07-14 | Hancock Mark |
Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.1727 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
10,296 |
| 2026-07-09 | Hancock Mark |
Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.255 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
4,966 |
| 2026-07-08 | Hancock Mark |
Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.2861 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
20,338 |
| 2026-07-06 | Hancock Mark |
Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.88 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
142,163 |
| 2026-07-06 | Lewis Michelle Renee |
Chief Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.15 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
4,137 |
| 2026-07-02 | Lewis Michelle Renee |
Chief Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.115 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
6,663 |
| 2026-07-02 | Hancock Mark |
Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.115 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
12,825 |
| 2026-07-01 | Lewis Michelle Renee |
Chief Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.06 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
4,200 |
| 2026-07-01 | Hancock Mark |
Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer. |
Common Stock
|
4,287 |
| 2026-07-01 | Hancock Mark |
Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.075 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
6,080 |
| 2026-07-01 | Conway Patrick Hugh |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer. |
Common Stock
|
4,287 |
| 2026-07-01 | LEAVITT TAYLOR S. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer. |
Common Stock
|
4,287 |